Suchergebnisse - "Smith, Patrick F"

PubPharm (126)

11

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers : A phase I, randomized study

enthalten in: Clinical and Translational Science | 2022

von Kallend, D. | Mason, J. | Smith, P. | +4

12

Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)

enthalten in: Clinical and Translational Science | 2022

von Owens, T. | Smith, P. | Redfern, A. | +8

13

A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects

enthalten in: Clinical and Translational Science | 2022

von Ucpinar, S. | Darpo, B. | Neale, A. | +8

14

Using in silico viral kinetic models to guide therapeutic strategies during a pandemic : An example in SARS-CoV-2

enthalten in: British journal of clinical pharmacology | 2021

von Patel, K. | Dodds, M. | Gonçalves, A. | +4

15

Blueprint for pandemic response : Focus on translational medicine, clinical pharmacology and pharmacometrics

enthalten in: British journal of clinical pharmacology | 2021

von Davda, J. | Reynolds, K. | Davis, J. | +1

16

Dosing will be a key success factor in repurposing antivirals for COVID-19

enthalten in: British journal of clinical pharmacology | 2021

von Smith, P. | Dodds, M. | Bentley, D. | +2

CommentIn: Br J Clin Pharmacol. 2021 Jan;87(1):212-213. - PMID 32384171

17

Monoclonal Antibody Treatment, Prophylaxis and Vaccines Combined to Reduce SARS CoV-2 Spread

enthalten in: bioRxiv.org | 2021

von Kamal, M. | Kuznik, A. | Qi, L. | +13

18

Model-Informed Drug Development for Anti-Infectives : State of the Art and Future

enthalten in: Clinical pharmacology and therapeutics | 2021

von Rayner, C. | Smith, P. | Andes, D. | +12

CommentIn: Clin Pharmacol Ther. 2021 Dec;110(6):1426-1428. - PMID 34555178

19

Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization

enthalten in: British journal of clinical pharmacology | 2021

von Sturm, S. | Lemenuel-Diot, A. | Patel, K. | +7

20

Dosing will be a key success factor in repurposing antivirals for COVID‐19

enthalten in: British Journal of Clinical Pharmacology | 2021

von Smith, P. | Dodds, M. | Bentley, D. | +2